These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
378 related articles for article (PubMed ID: 25960420)
1. The extracellular matrix and transforming growth factor-β1: Tale of a strained relationship. Hinz B Matrix Biol; 2015 Sep; 47():54-65. PubMed ID: 25960420 [TBL] [Abstract][Full Text] [Related]
2. The single-molecule mechanics of the latent TGF-β1 complex. Buscemi L; Ramonet D; Klingberg F; Formey A; Smith-Clerc J; Meister JJ; Hinz B Curr Biol; 2011 Dec; 21(24):2046-54. PubMed ID: 22169532 [TBL] [Abstract][Full Text] [Related]
3. Integrins and the activation of latent transforming growth factor beta1 - an intimate relationship. Wipff PJ; Hinz B Eur J Cell Biol; 2008 Sep; 87(8-9):601-15. PubMed ID: 18342983 [TBL] [Abstract][Full Text] [Related]
4. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3). Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708 [TBL] [Abstract][Full Text] [Related]
5. TGF-β1 - A truly transforming growth factor in fibrosis and immunity. Lodyga M; Hinz B Semin Cell Dev Biol; 2020 May; 101():123-139. PubMed ID: 31879265 [TBL] [Abstract][Full Text] [Related]
6. Prestress in the extracellular matrix sensitizes latent TGF-β1 for activation. Klingberg F; Chow ML; Koehler A; Boo S; Buscemi L; Quinn TM; Costell M; Alman BA; Genot E; Hinz B J Cell Biol; 2014 Oct; 207(2):283-97. PubMed ID: 25332161 [TBL] [Abstract][Full Text] [Related]
7. Dexamethasone enhances cell resistance to chemotherapy by increasing adhesion to extracellular matrix in human ovarian cancer cells. Chen YX; Wang Y; Fu CC; Diao F; Song LN; Li ZB; Yang R; Lu J Endocr Relat Cancer; 2010 Mar; 17(1):39-50. PubMed ID: 19776289 [TBL] [Abstract][Full Text] [Related]
8. TGF-beta1 (transforming growth factor-beta1)-mediated adhesion of gastric carcinoma cells involves a decrease in Ras/ERKs (extracellular-signal-regulated kinases) cascade activity dependent on c-Src activity. Kim HP; Lee MS; Yu J; Park JA; Jong HS; Kim TY; Lee JW; Bang YJ Biochem J; 2004 Apr; 379(Pt 1):141-50. PubMed ID: 14720123 [TBL] [Abstract][Full Text] [Related]
10. Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Hinz B Curr Rheumatol Rep; 2009 Apr; 11(2):120-6. PubMed ID: 19296884 [TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system. Ghahary A; Tredget EE; Shen Q J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018 [TBL] [Abstract][Full Text] [Related]
12. Role of carbohydrate structures in the binding of beta1-latency-associated peptide to ligands. Yang Y; Dignam JD; Gentry LE Biochemistry; 1997 Sep; 36(39):11923-32. PubMed ID: 9305986 [TBL] [Abstract][Full Text] [Related]
13. Latent transforming growth factor-β1 protects against bleomycin-induced lung injury in mice. Tang YJ; Xiao J; Huang XR; Zhang Y; Yang C; Meng XM; Feng YL; Wang XJ; Hui DS; Yu CM; Lan HY Am J Respir Cell Mol Biol; 2014 Dec; 51(6):761-71. PubMed ID: 24885478 [TBL] [Abstract][Full Text] [Related]
14. The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Heeg MH; Koziolek MJ; Vasko R; Schaefer L; Sharma K; Müller GA; Strutz F Kidney Int; 2005 Jul; 68(1):96-109. PubMed ID: 15954899 [TBL] [Abstract][Full Text] [Related]
15. Role of caveolin-1 in fibrotic diseases. Gvaramia D; Blaauboer ME; Hanemaaijer R; Everts V Matrix Biol; 2013 Aug; 32(6):307-15. PubMed ID: 23583521 [TBL] [Abstract][Full Text] [Related]
16. MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1. Tatti O; Vehviläinen P; Lehti K; Keski-Oja J Exp Cell Res; 2008 Aug; 314(13):2501-14. PubMed ID: 18602101 [TBL] [Abstract][Full Text] [Related]
17. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes. Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347 [TBL] [Abstract][Full Text] [Related]
18. Matrix-associated latent TGF-beta with latent TGF-beta binding protein in the progressive process in adriamycin-induced nephropathy. Tamaki K; Okuda S; Miyazono K; Nakayama M; Fujishima M Lab Invest; 1995 Jul; 73(1):81-9. PubMed ID: 7603044 [TBL] [Abstract][Full Text] [Related]
19. Regulation of transforming growth factor-β1 activation and expression in the tissue remodeling involved in chronic rhinosinusitis. Kou W; Hu GH; Yao HB; Wang XQ; Shen Y; Kang HY; Hong SL ORL J Otorhinolaryngol Relat Spec; 2012; 74(3):172-8. PubMed ID: 22678103 [TBL] [Abstract][Full Text] [Related]
20. Effects of transforming growth factor beta1 on bonelike tissue formation in three-dimensional cell culture. I. Culture conditions and tissue formation. Lieb E; Milz S; Vogel T; Hacker M; Dauner M; Schulz MB Tissue Eng; 2004; 10(9-10):1399-413. PubMed ID: 15588400 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]